Sorafenib in Treating Patients With Advanced Solid Tumors

NCT00436579 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

110

Enrollment

NIH

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: sorafenib tosylate
OTHER: pharmacological study
PROCEDURE: assessment of therapy complications
OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)